SCIASCIA THOMAS
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to SCIASCIA THOMAS. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TRVI | Chief Scientific Officer | Option Exercise | 2,631 | $1.43 | $3,762 | Mar 25, 2025 |
| TRVI | Chief Scientific Officer | Sale | 16,496 | $2.96 | $48,828 | Aug 19, 2024 |
| TRVI | Chief Scientific Officer | Sale | 12,745 | $2.79 | $35,559 | Aug 16, 2024 |
| TRVI | Chief Scientific Officer | Option Exercise | 59,354 | $2.19 | $129,985 | May 29, 2024 |
| TRVI | Chief Medical Officer | C | 17,118 | — | — | May 9, 2019 |
| 0001047188 | SVP Clin Dev & Reg Aff & CMO | U | 40,494 | — | — | Sep 20, 2010 |